Motley Fool Premium
  1. Stocks
    2. /
  2. Aptose Biosciences (TSX: APS)
    3. /

TSX:APS (Aptose Biosciences)

About APS

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Aptose Biosciences (TSX: APS) Latest News

    Investing

    Is it Time to Buy the TSX’s 3 Worst-Performing Canadian Stocks?

    | Ambrose O'Callaghan

    Canadian stocks like Yellow Pages Limited (TSX:Y) have been throttled over the past year, but investors shouldn’t necessarily look past…

    Read more »

    Investing

    Aptose Biosciences Climbs 17% to Reclaim Some Losses

    | Amy Legate-Wolfe

    Aptose Biosciences (TSX:APS)(NASDAQ:APTO) recovered 17% after losing 45% this week from results of its drug trial gave investors a wait-and-see…

    Read more »

    Investing

    Why Aptose Biosciences Plunged 45% Yesterday

    | Amy Legate-Wolfe

    Aptose Biosciences (TSX:APT)(NASDAQ:APTO) results for its leukemia drug were met with a poor reaction, sending shares down 45%.

    Read more »

    Coronavirus

    3 TSX Stocks Bay Street Expects Could Double or Triple in 1 Year!

    | Amy Legate-Wolfe

    There are lots of TSX stocks out there that continue to be a deal, but these three offer the best…

    Read more »

    Dividend Stocks

    5 Top TSX Stocks to Buy Amid a Market Rally in April 2021

    | Jitendra Parashar

    Investors can buy these five rallying stocks in April 2021 to benefit from the ongoing market rally.

    Read more »

    Investing

    ACT NOW: 1 Pharma Stock That Could Triple in Value

    | Nikhil Kumar

    Aptose Biosciences Inc. (TSX:APS) is a science-driven biotechnology company producing medicines to cure cancer. The company's shares could rise significantly…

    Read more »

    Coronavirus

    1 Potentially Life-Changing Stock

    | Jed Lloren

    Research suggests that one in two people will be diagnosed with cancer at some point in their lives. This company…

    Read more »

    Dividend Stocks

    Market Crash Lessons: 3 Stocks That Show Cash Is King

    | Adam Othman

    Holding on to cash is a necessity for almost all businesses. Not all companies do, and it's a mistake, which…

    Read more »

    Investing

    Fear a Recession in 2020? Buy This Cheap Biotech Stock

    | Nikhil Kumar

    If Aptose Biosciences Inc (TSX:APS) is successful at treating life-threatening cancers, the stock could see a huge increase in value,…

    Read more »